A guide to cancer immunotherapy: from T cell basic science to clinical practice

2020/05/20 by Alex D. Waldman, Jill M. Fritz, Michael J. Lenardo · 34 citations
Immunology and Microbiology · Medicine · #CAR-T cell therapy research #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses

paper · pdf · doi:10.1038/s41577-020-0306-5

crossref issued 2020/05/20 · crossref published 2020/05/20 · crossref published-online 2020/05/20 · openalex publication_date 2020/05/20 · crossref created 2020/05/20 · crossref published-print 2020/11/01 · crossref deposited 2024/12/11 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Cited by

• Real‐Time Monitoring of DNA Origami‐Cell Interactions via Single Particle Tracking
• Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticity
• Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation
• Tissue-specific antitumor NK cell subsets identified in colorectal cancer liver metastases express candidate therapeutic targets
• P-stalk ribosomes act as master regulators of cytokine-mediated processes
• Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis
• Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
• Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
• Rational Design of Immune Gene Therapy Combinations via <i>In Vivo</i> CRISPR Activation Screen of Tumor Microenvironment Modulators
• Conserved programs and specificities of T cells targeting hematological malignancies
• Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
• Epigenetic regulation of T cell adaptive immunity
• Electrospinning and electrospun nanofibers: From academic research to industrial production
• Applied research won’t flourish without basic science
• The Fast‐Growing Field of Cancer Immunotherapy Based on Aggregation‐Induced Emission
• Clinical and experimental treatment of advanced melanoma with a focus on immunotherapy
• Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
• SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases
• Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties
• Single‐Cell and Spatial Multiomics: Applications for Diseases
• PD-1 Blockade–Induced DKK1 Expression by CD8+ T Cells Promotes Blood–Brain Barrier Permeabilization
• Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides
• Identification of the immunotherapy susceptibility of solid cancer using noninvasive in vivo bioluminescence optical imaging of NF-κB activation for precision medicine
• Generalization of neoantigen-based tumor vaccine by delivering peptide-MHC complex via oncolytic virus
• Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review
• Metallodrugs: From mere cytotoxic agents to immune modulators and checkpoint inhibitors
• Can we predict T cell specificity with digital biology and machine learning?
• Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)
• A Melanoma-Specific Gene Network Analysis Identifies MZB1 as a Potential Tumor Promoter
• Crosstalk Between Cancer‐Associated Fibroblasts and Immune Cells: Mechanisms and Therapeutic Implications
• Multimodal framework for the joint analysis of single-cell RNA and T cell receptor sequencing data predicts T cell response to cancer immunotherapy
• mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives
• Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
• Advances and mechanisms of gut microbiota modulation in enhancing immune checkpoint inhibitor efficacy